Your browser doesn't support javascript.
loading
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study.
Visentin, Andrea; Mauro, Francesca Romana; Scarfò, Lydia; Gentile, Massimo; Farina, Lucia; Reda, Gianluigi; Ferrarini, Isacco; Proietti, Giulia; Derenzini, Enrico; Cibien, Francesca; Vitale, Candida; Sanna, Alessandro; Pietrasanta, Daniela; Marchetti, Monia; Murru, Roberta; Rigolin, Gian Matteo; Sportoletti, Paolo; Trimarco, Valentina; Cavarretta, Chiara Adele; Angotzi, Francesco; Cellini, Alessandro; Ruocco, Valeria; Zatta, Ivan; Laurenti, Luca; Molica, Stefano; Coscia, Marta; Ghia, Paolo; Foà, Robin; Cuneo, Antonio; Trentin, Livio.
Afiliación
  • Visentin A; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Mauro FR; Veneto Institute of Molecular Medicine, Padua, Italy.
  • Scarfò L; Hematology, Department of Translational and Precision Medicine, "Sapienza" University, Rome, Italy.
  • Gentile M; Strategic Research Program on CLL, Università Vita-salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy.
  • Farina L; Hematology Unit, Azienda Ospedaliera of Cosenza, Cosenza, Italy.
  • Reda G; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy.
  • Ferrarini I; Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Proietti G; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore, University of Milan, Milan, Italy.
  • Derenzini E; Department of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Cibien F; Hematology, Department of Translational and Precision Medicine, "Sapienza" University, Rome, Italy.
  • Vitale C; Divisions of Haemato-oncology, Haematology Programme, European Institute of Oncology IRCCS, Milan, Italy.
  • Sanna A; Hematology Unit, Ca' Foncello Hospital, Treviso, Italy.
  • Pietrasanta D; Department of Molecular Biotechnology and Health Sciences, University of Torino and Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy.
  • Marchetti M; Hematology Unit, Department of Oncology, AOU Careggi, Florence, Italy.
  • Murru R; Division of Hematology, A.O. SS Antonio e Biagio and Cesare Arrigo, Alessandria, Italy.
  • Rigolin GM; Division of Hematology, A.O. SS Antonio e Biagio and Cesare Arrigo, Alessandria, Italy.
  • Sportoletti P; Hematology and Stem Cell Transplantation Unit, Ospedale A. Businco, ARNAS G. Brotzu, Cagliari, Italy.
  • Trimarco V; Hematology Section, Department of Medical Sciences, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, University of Ferrara, Ferrara, Italy.
  • Cavarretta CA; Institute of Hematology and Center for Hemato-Oncology Research, University of Perugia and Santa Maria della Misericordia Hospital, Perugia, Italy.
  • Angotzi F; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Cellini A; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Ruocco V; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Zatta I; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Laurenti L; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Molica S; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Coscia M; Hematology Institute, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy.
  • Ghia P; Center of biomedicine, University of Hull, Hull, UK.
  • Foà R; Department of Molecular Biotechnology and Health Sciences, University of Torino and Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy.
  • Cuneo A; Strategic Research Program on CLL, Università Vita-salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy.
  • Trentin L; Hematology, Department of Translational and Precision Medicine, "Sapienza" University, Rome, Italy.
Am J Hematol ; 98(9): E237-E240, 2023 09.
Article en En | MEDLINE | ID: mdl-37382471
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Antineoplásicos Límite: Humans Idioma: En Revista: Am J Hematol Año: 2023 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Antineoplásicos Límite: Humans Idioma: En Revista: Am J Hematol Año: 2023 Tipo del documento: Article País de afiliación: Italia